Accendra Total Operating Expenses from 2010 to 2026
| ACH Stock | USD 2.21 0.13 6.25% |
Total Operating Expenses | First Reported 1985-09-30 | Previous Quarter 364.3 M | Current Value 295.7 M | Quarterly Volatility 195.3 M |
Check Accendra Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accendra Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 319.7 M, Interest Expense of 173.6 M or Total Revenue of 12.9 B, as well as many indicators such as Price To Sales Ratio of 0.0058, Dividend Yield of 0.0049 or PTB Ratio of 0.0884. Accendra financial statements analysis is a perfect complement when working with Accendra Health Valuation or Volatility modules.
Accendra | Total Operating Expenses | Build AI portfolio with Accendra Stock |
The Total Operating Expenses trend for Accendra Health offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Accendra Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Accendra Health's Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of Accendra Health over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. Accendra Health's Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Accendra Health's overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
Accendra Total Operating Expenses Regression Statistics
| Arithmetic Mean | 1,351,838,666 | |
| Geometric Mean | 1,041,282,961 | |
| Coefficient Of Variation | 57.67 | |
| Mean Deviation | 607,568,039 | |
| Median | 1,076,716,000 | |
| Standard Deviation | 779,660,439 | |
| Sample Variance | 607870.4T | |
| Range | 2.9B | |
| R-Value | 0.91 | |
| Mean Square Error | 116135.2T | |
| R-Squared | 0.82 | |
| Slope | 139,887,025 | |
| Total Sum of Squares | 9725926.4T |
Accendra Total Operating Expenses History
About Accendra Health Financial Statements
Investors use fundamental indicators, such as Accendra Health's Total Operating Expenses, to determine how well the company is positioned to perform in the future. Although Accendra Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Total Operating Expenses | 2.8 B | 2.9 B |
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Check out the analysis of Accendra Health Correlation against competitors. For more detail on how to invest in Accendra Stock please use our How to Invest in Accendra Health guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is there potential for Medical Distribution market expansion? Will Accendra introduce new products? Factors like these will boost the valuation of Accendra Health. If investors know Accendra will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Accendra Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Accendra Health requires distinguishing between market price and book value, where the latter reflects Accendra's accounting equity. The concept of intrinsic value—what Accendra Health's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Accendra Health's price substantially above or below its fundamental value.
Understanding that Accendra Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Accendra Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Accendra Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.